All subjects (n = 66) | Returning subjects (n = 56) | |
---|---|---|
Values are mean (SD) or percentage. | ||
5-ASA, 5-aminosalicylic acid; UCDAI, ulcerative colitis disease activity index; SCCAI, simple clinical colitis activity index; IBDQ, inflammatory bowel disease quality of life index. | ||
Characteristic | ||
Age (y) | 40.5 (15.2) | 40.8 (15.4) |
Female | 54.6% | 53.6% |
Caucasian | 89.4% | 89.3% |
African-American | 6.1% | 5.4% |
Oral 5-ASA use | 77.3% | 76.8% |
Rectal therapy use | 21.2% | 23.2% |
Steroid use | 25.7% | 25.0% |
Thiopurine use | 21.2% | 19.6% |
Activity index or extent | ||
St Mark’s index | 5.28 (4.23) | 5.36 (4.11) |
UCDAI | 4.64 (3.94) | 4.64 (3.97) |
SCCAI | 4.00 (3.84) | 3.96 (3.86) |
Seo index | 141.07 (52.42) | 142.07 (52.11) |
IBDQ | 179.21 (48.00) | 181.52 (47.28) |
% Proctitis | 13.6% | 14.3% |
% Left Sided | 36.4% | 33.9% |
% Pancolitis | 50.0% | 51.7% |